evan-stein documents

Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia
Documents Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia
Laboratory surrogates for anti-atherosclerotic drug development
Documents Laboratory surrogates for anti-atherosclerotic drug development
Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety
Documents Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety
Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia
Documents Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia
Cerivastatin in primary hyperlipidemia—a multicenter analysis of efficacy and safety
Documents Cerivastatin in primary hyperlipidemia—a multicenter analysis of efficacy and safety
Baltimore single 'No Panic' press release
Documents Baltimore single 'No Panic' press release
Swiss Miss Ad Plan Booklet
Documents Swiss Miss Ad Plan Booklet